• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 时代肺部曲霉菌病研究趋势:有何变化?

Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?

机构信息

Interdisciplinary Department of Medicine, Hygiene Section, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.

Department of Biomedical Science and Human Oncology, University of Bari Aldo Moro, Piazza G. Cesare 11, 70124 Bari, Italy.

出版信息

Int J Environ Res Public Health. 2022 Jun 9;19(12):7079. doi: 10.3390/ijerph19127079.

DOI:10.3390/ijerph19127079
PMID:35742328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9222563/
Abstract

Aspergillosis is a disease caused by , and invasive pulmonary aspergillosis (IPA) is the most common invasive fungal infection leading to death in severely immuno-compromised patients. The literature reports co-infections in patients with COVID-19 (CAPA). Diagnosing CAPA clinically is complex since the symptoms are non-specific, and performing a bronchoscopy is difficult. Generally, the microbiological diagnosis of aspergillosis is based on cultural methods and on searching for the circulating antigens galactomannan and 1,3-β-D-glucan in the bronchoalveolar lavage fluid (bGM) or serum (sGM). In this study, to verify whether the COVID-19 period has stimulated clinicians to pay greater attention to IPA in patients with respiratory tract infections, we evaluated the number of requests for GM-Ag research and the number of positive tests found during the pre-COVID-19 and COVID-19 periods. Our data show a significant upward trend in GM-Ag requests and positivity from the pre-COVID to COVID period, which is attributable in particular to the increase in IPA risk factors as a complication of COVID-19. In the COVID period, parallel to the increase in requests, the number of positive tests for GM-Ag also increased, going from 2.5% in the first period of 2020 to 12.3% in the first period of 2021.

摘要

曲霉菌病是由曲霉菌引起的疾病,侵袭性肺曲霉病(IPA)是导致严重免疫功能低下患者死亡的最常见侵袭性真菌感染。文献报道 COVID-19(CAPA)患者存在合并感染。由于症状不特异,临床诊断 CAPA 较为复杂,且支气管镜检查较为困难。一般来说,曲霉病的微生物学诊断基于培养方法以及检测支气管肺泡灌洗液(bGM)或血清(sGM)中半乳甘露聚糖和 1,3-β-D-葡聚糖的循环抗原。在这项研究中,为了验证 COVID-19 期间是否促使临床医生更加关注呼吸道感染患者的 IPA,我们评估了 GM-Ag 研究的请求数量和在 COVID-19 之前和期间发现的阳性测试数量。我们的数据显示,从 COVID-19 之前到 COVID-19 期间,GM-Ag 请求和阳性率呈显著上升趋势,这主要归因于 COVID-19 并发症 IPA 风险因素的增加。在 COVID-19 期间,与请求数量的增加平行,GM-Ag 阳性测试的数量也从 2020 年第一季度的 2.5%增加到 2021 年第一季度的 12.3%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6743/9222563/e6a6309d065d/ijerph-19-07079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6743/9222563/e6a6309d065d/ijerph-19-07079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6743/9222563/e6a6309d065d/ijerph-19-07079-g001.jpg

相似文献

1
Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?COVID-19 时代肺部曲霉菌病研究趋势:有何变化?
Int J Environ Res Public Health. 2022 Jun 9;19(12):7079. doi: 10.3390/ijerph19127079.
2
Active screening of COVID-19-associated pulmonary aspergillosis with serum beta-glucan and endotracheal aspirates galactomannan and fungal culture.采用血清β-葡聚糖、气管内吸出物半乳甘露聚糖和真菌培养对新型冠状病毒肺炎相关肺曲霉病进行主动筛查。
Mycoses. 2023 Mar;66(3):219-225. doi: 10.1111/myc.13545. Epub 2022 Nov 20.
3
Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.危重症患者 COVID-19 相关侵袭性肺曲霉病的危险因素及微生物学检查价值:及时诊断 CAPA 时,合适的微生物学检查至关重要。
Front Cell Infect Microbiol. 2023 Nov 21;13:1287496. doi: 10.3389/fcimb.2023.1287496. eCollection 2023.
4
COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.COVID-19 相关侵袭性曲霉病:来自英国国家真菌学参考实验室的数据。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.02136-20.
5
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study.COVID-19 重症监护病房患者生存的支气管肺泡灌洗液半乳甘露聚糖和曲霉培养结果的预后影响:来自欧洲医学真菌学联合会(ECMM)COVID-19 相关肺曲霉病研究的分析。
J Clin Microbiol. 2022 Apr 20;60(4):e0229821. doi: 10.1128/jcm.02298-21. Epub 2022 Mar 24.
6
Evaluation of -Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.应用于血清和支气管肺泡灌洗液的半乳甘露聚糖检测试验在慢性肺曲霉病诊断中的评价。
J Clin Microbiol. 2019 Apr 26;57(5). doi: 10.1128/JCM.00095-19. Print 2019 May.
7
Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.用支气管肺泡灌洗液进行半乳甘露聚糖、β - D - 葡聚糖、曲霉侧流装置、传统培养及PCR检测诊断侵袭性肺曲霉病的性能
J Clin Microbiol. 2014 Jun;52(6):2039-45. doi: 10.1128/JCM.00467-14. Epub 2014 Mar 26.
8
Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.用于 COVID-19 相关肺曲霉病 (CAPA) 诊断的曲霉侧向流检测与数字读取器:一项多中心研究。
J Clin Microbiol. 2022 Jan 19;60(1):e0168921. doi: 10.1128/JCM.01689-21. Epub 2021 Oct 13.
9
COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.深圳市一家三级保健中心的 COVID-19 相关肺曲霉病。
J Infect Public Health. 2022 Feb;15(2):222-227. doi: 10.1016/j.jiph.2021.12.015. Epub 2022 Jan 6.
10
Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.在免疫抑制的机械通气重症患者中,比较血清和支气管肺泡灌洗液中1,3-β-D-葡聚糖与半乳甘露聚糖用于检测曲霉菌种的情况。
J Crit Care. 2016 Dec;36:259-264. doi: 10.1016/j.jcrc.2016.06.026. Epub 2016 Jul 9.

引用本文的文献

1
in the Food Production Chain and Azole Resistance: A Growing Concern for Consumers.食品生产链中的唑类抗性:消费者日益关注的问题。
J Fungi (Basel). 2025 Mar 26;11(4):252. doi: 10.3390/jof11040252.
2
Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.美国2019冠状病毒病相关肺曲霉病的发病率及住院治疗结果
Ann Thorac Med. 2024 Jan-Mar;19(1):87-95. doi: 10.4103/atm.atm_190_23. Epub 2024 Jan 25.
3
COVID-19-associated pulmonary aspergillosis (CAPA): identification of Aspergillus species and determination of antifungal susceptibility profiles.

本文引用的文献

1
Utility of serum Galactomannan in diagnosing COVID-19 patients with suspected IPA: an observational study in resource limited settings.血清半乳甘露聚糖在诊断 COVID-19 合并 IPA 疑似患者中的作用:资源有限环境下的观察性研究。
Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):710-714. doi: 10.26355/eurrev_202201_27897.
2
Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19.肺曲霉病和隐球菌病作为新冠病毒感染疾病(COVID-19)的并发症
Med Mycol Case Rep. 2022 Mar;35:22-25. doi: 10.1016/j.mmcr.2022.01.003. Epub 2022 Jan 6.
3
Clinician variability in the diagnosis and treatment of aspergillus fumigatus-related conditions in cystic fibrosis: An international survey.
COVID-19 相关肺曲霉病(CAPA):曲霉属菌种鉴定及抗真菌药敏谱测定。
Folia Microbiol (Praha). 2023 Dec;68(6):951-959. doi: 10.1007/s12223-023-01069-5. Epub 2023 Jun 9.
4
Severe Recurrent COVID-Associated Pulmonary Aspergillosis: A Challenging Case.重症复发性新型冠状病毒肺炎相关肺曲霉病:1例具有挑战性的病例
Healthcare (Basel). 2022 Dec 8;10(12):2483. doi: 10.3390/healthcare10122483.
囊性纤维化中烟曲霉相关疾病的诊断和治疗中临床医生的变异性:一项国际调查。
J Cyst Fibros. 2022 Jan;21(1):136-142. doi: 10.1016/j.jcf.2021.07.008. Epub 2021 Jul 29.
4
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization.抗白细胞介素 5/5 受体治疗在伴有真菌致敏的严重特应性嗜酸性哮喘中的真实世界疗效。
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2315-2320.e1. doi: 10.1016/j.jaip.2021.02.048. Epub 2021 Mar 6.
5
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病:2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
6
Invasive Pulmonary Aspergillosis in Patients with SARS-CoV-2 Infection: A Systematic Review of the Literature.2019冠状病毒病患者的侵袭性肺曲霉病:文献系统评价
Diagnostics (Basel). 2020 Oct 10;10(10):807. doi: 10.3390/diagnostics10100807.
7
A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit.国家策略诊断 2019 冠状病毒疾病相关重症监护室侵袭性真菌感染。
Clin Infect Dis. 2021 Oct 5;73(7):e1634-e1644. doi: 10.1093/cid/ciaa1298.
8
COVID-19 and fungal superinfection.新型冠状病毒肺炎与真菌二重感染
Lancet Microbe. 2020 Jul;1(3):e107. doi: 10.1016/S2666-5247(20)30065-3. Epub 2020 Jul 3.
9
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学:一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
10
Confirmed Invasive Pulmonary Aspergillosis and COVID-19: the value of postmortem findings to support antemortem management.确诊侵袭性肺曲霉病和 COVID-19:尸检结果对支持生前治疗的价值。
Rev Soc Bras Med Trop. 2020;53:e20200401. doi: 10.1590/0037-8682-0401-2020. Epub 2020 Jul 3.